Investigacion Biomedica para el Desarrollo de Farmacos, S.A. de C.V. /ID# 167648

Zapopan, Jalisco 45070

0 studies enrolling now · 1 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease — Completed